{"id":"hdm1002-400mg-oral-once-daily-52-weeks","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Without publicly available detailed mechanism information for HDM1002, the precise molecular target and pathway remain unclear. The drug is in Phase 3 development by a Chinese pharmaceutical company, suggesting it is being evaluated for a significant therapeutic indication. Further clinical trial data would be needed to characterize its exact mechanism of action.","oneSentence":"HDM1002 is a small molecule inhibitor that targets a specific molecular pathway involved in metabolic or inflammatory disease.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:15:01.099Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07082114","phase":"PHASE3","title":"A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2025-07-14","conditions":"Type 2 Diabetes","enrollment":800},{"nctId":"NCT06885021","phase":"PHASE3","title":"Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese Adults","status":"NOT_YET_RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2025-03-28","conditions":"Overweight and Obesity","enrollment":780}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"HDM1002 400mg, oral, once daily, 52 weeks","genericName":"HDM1002 400mg, oral, once daily, 52 weeks","companyName":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","companyId":"hangzhou-zhongmei-huadong-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}